EPILEPSYGTX LIMITED

Active Canterbury

Research and experimental development on biotechnology

2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EPILEPSYGTX LIMITED

Research and experimental development on biotechnology

Founded 24 May 2021 Active Canterbury, United Kingdom 2 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 5 months remaining
Confirmation
Net assets £-410K £2M 2024 year on year
Total assets £1M £413K 2024 year on year
Total Liabilities £2M £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Camburgh House 27 New Dover Road Canterbury Kent CT1 3DN United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for EPILEPSYGTX LIMITED (13415161), an active life sciences and medical technology company based in Canterbury, United Kingdom. Incorporated 24 May 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£1.08M

Decreased by £204.87k (-16%)

Net Assets

-£410.07k

Decreased by £1.66M (-133%)

Total Liabilities

£1.74M

Increased by £1.24M (+252%)

Turnover

N/A

Employees

2

Increased by 1 (+100%)

Debt Ratio

131%

Increased by 103 (+368%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 1

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jun 2024Seed
Investor 2Jun 2024Seed
Investor 3Jun 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 14,846,521 Shares £16.36m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Dec 20256,250,000£12.50m£2
23 Dec 2025906,755£1.36m£1.5
30 Oct 20231,500,000£1.50m£1
4 May 20231,000,000£1.00m£1
3 Sept 20212,594,883£25.949£0

Officers

Officers

2 active 1 resigned
Status
Jan Edward ThirkettleDirectorBritishUnited Kingdom549 May 2022Active
Nicolas KoebelDirectorFrench,britishEngland549 Nov 2022Active

Shareholders

Shareholders (8)

Utf General Partner 2 Llp (in Its Capacity As A General Partner Of Ucl Technology Fund 2 Lp)
35.4%
4,000,000
Ucl Business Ltd
17.1%
1,933,397

Persons with Significant Control

Persons with Significant Control (2)

2 Active 3 Ceased
Active
Notified 10 Feb 2025
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Ucl Business Ltd

United Kingdom

Active
Notified 24 May 2022
Nature of Control
  • Right To Appoint And Remove Directors

Ucl Business Ltd

Ceased 2 Aug 2022

Ceased

Albion Capital Group Llp

Ceased 23 May 2023

Ceased

Dimitri Michael Kullmann

Ceased 9 May 2022

Ceased

Group Structure

Group Structure

UCL BUSINESS LTD united kingdom
EPILEPSYGTX LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 Mar 2026ResolutionResolutions
28 Mar 2026IncorporationMemorandum Articles
26 Mar 2026ResolutionResolutions
26 Mar 2026IncorporationMemorandum Articles
20 Mar 2026CapitalAllotment of shares (GBP 200.29276) on 2026-03-12
28 Mar 2026 Resolution

Resolutions

28 Mar 2026 Incorporation

Memorandum Articles

26 Mar 2026 Resolution

Resolutions

26 Mar 2026 Incorporation

Memorandum Articles

20 Mar 2026 Capital

Allotment of shares (GBP 200.29276) on 2026-03-12

Recent Activity

Latest Activity

Resolutions

3 weeks ago on 28 Mar 2026

Memorandum Articles

3 weeks ago on 28 Mar 2026

Resolutions

3 weeks ago on 26 Mar 2026

Memorandum Articles

3 weeks ago on 26 Mar 2026

Allotment of shares (GBP 200.29276) on 2026-03-12

1 months ago on 20 Mar 2026